AU Stock MarketDetailed Quotes
PYCDA PYC Therapeutics Ltd
- 1.850
- +0.010+0.54%
20min DelayMarket Closed Nov 25 16:00 AET
863.23MMarket Cap-19270P/E (Static)
1.900High1.820Low159.67KVolume1.870Open1.840Pre Close297.84KTurnover1.95552wk High0.07%Turnover Ratio466.61MShares1.70052wk Low-0.096EPS TTM436.98MFloat Cap1.955Historical HighLossP/E (Static)236.21MShs Float1.700Historical Low-0.096EPS LYR4.35%Amplitude--Dividend TTM10.69P/B1Lot Size--Div YieldTTM
About PYC Therapeutics Ltd Company
PYC Therapeutics Ltd is an RNA therapeutics drug development company, leveraging a proprietary delivery platform to solve the challenges in RNA therapeutics - safe and effective delivery of the drug inside the cell. The company's principal business activity is of of drug development and progressing the company’s drug pipeline through preclinical and clinical development. Geographically, it operates only in Australia.
Company Profile
SymbolPYCDA
Company NamePYC Therapeutics Ltd
Founded2001
MarketASX
Employees5
Fiscal Year Ends06-30
Address6 Verdun Street Harry Perkins Institute of Medical Research
CityPerth
CountryAustralia
Zip Code6009
Phone+61 861510992
Websitehttps://www.pyctx.com
Share RegistryAUTOMIC REGISTRY SERVICES
LEVEL 5, 191 St Georges Terrace,, PERTH, WA, AUSTRALIA, 6000
(08) 9324 2099
Company Executives
- Name
- Position
- Salary
- Rohan Hockings
- Executive Director,Chief Executive Officer
- --
- Alan William Tribe
- Non-Executive Chairman,Non-Executive Director
- --
- Michael Rosenblatt
- Non-Executive Director
- --
- Jason Haddock
- Non-Executive Director
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data